Pharmaceutical

Serono Laboratories Inc., based in Norwell, Mass., plans to consolidate its offices and labs at a new $20 million, 200,000-sf headquarters that will straddle the town line between Hingham and Rockland. A.W. Perry Inc. of Boston is the developer on the project. Construction has not yet begun, but move-in is scheduled for late 2000.

Serono Labs is a drug-development company and a subsidiary of Ares-Serono Group SA of Geneva, Switz.

EMD Pharmaceuticals, a subsidiary of Germany-based Merck KgaA, is building a 148,000-sf marketing, sales, and clinical research facility in Durham. The Indra Group is the developer of the project.